Programme

Lecture Theatre 1A
2021-09-04
09:00-10:30
CRC: prevention is better than cure
Chair : Simon NG and Joseph SUNG
09:00
Should routine CRC screening start at 45: latest recommendations
09:30
Novel non-invasive markers for colorectal cancer and adenoma detection
10:00
Precision nutrition and the gut microbiome: Implications for cancer prevention
Lecture Theatre 1A
2021-09-04
11:00-12:30
Prime time microbiome therapeutics
Chair : Margaret IP and Siew NG
11:00
Microbiome restoration therapy in C. difficile infection: new clinical trial data
11:30
FMT in Singapore: current practice and journey to commercialization
12:00
FMT for emerging indications other than C. difficile: the Nanjing experience
Lecture Theatre 1A
2021-09-04
16:10-17:40
Advancing science in the pandemic
Chair : Jodis LAM and Siew NG
16:10
Top 10 highlights from practice changing research in GUT
16:40
Latest recommendation on COVID-19 vaccine in GI diseases
17:10
What’s new in GI oncology?
Lecture Theatre 1A
2021-09-04
17:40-18:40
New kids on the block in IBD
Chair : Michael LI and Joyce MAK
17:40
Pioneering JAK Science series – new molecule treatment ready for clinical use
18:15
Choosing and positioning therapies for ulcerative colitis
Lecture Theatre 1A
2021-09-05
14:30-16:00
Update in gastrointestinal disorders
Chair : Heyson CHAN and Justin WU
14:30
Evidence-based approach in management of IBS?
15:00
Modulation of gut microbiome for COVID-19
15:30
GI risk, CVS risk and anticoagulants: double-edged sword
CRC: prevention is better than cure
Lecture Theatre 1A
2021-09-04
09:00
Chair : Simon NG and Joseph SUNG
09:00
Should routine CRC screening start at 45: latest recommendations
09:30
Novel non-invasive markers for colorectal cancer and adenoma detection
10:00
Precision nutrition and the gut microbiome: Implications for cancer prevention
Prime time microbiome therapeutics
Lecture Theatre 1A
2021-09-04
11:00
Chair : Margaret IP and Siew NG
11:00
Microbiome restoration therapy in C. difficile infection: new clinical trial data
11:30
FMT in Singapore: current practice and journey to commercialization
12:00
FMT for emerging indications other than C. difficile: the Nanjing experience
Advancing science in the pandemic
Lecture Theatre 1A
2021-09-04
16:10
Chair : Jodis LAM and Siew NG
16:10
Top 10 highlights from practice changing research in GUT
16:40
Latest recommendation on COVID-19 vaccine in GI diseases
17:10
What’s new in GI oncology?
New kids on the block in IBD
Lecture Theatre 1A
2021-09-04
17:40
Chair : Michael LI and Joyce MAK
17:40
Pioneering JAK Science series – new molecule treatment ready for clinical use
18:15
Choosing and positioning therapies for ulcerative colitis
Update in gastrointestinal disorders
Lecture Theatre 1A
2021-09-05
14:30
Chair : Heyson CHAN and Justin WU
14:30
Evidence-based approach in management of IBS?
15:00
Modulation of gut microbiome for COVID-19
15:30
GI risk, CVS risk and anticoagulants: double-edged sword